Sage Therapeutics, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sage Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Sage Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -50.3 %, a 19.8% increase year-over-year.
  • Sage Therapeutics, Inc. annual Return On Equity for 2023 was -58 %, a 56.7% decline from 2022.
  • Sage Therapeutics, Inc. annual Return On Equity for 2022 was -37 %, a 51.6% decline from 2021.
  • Sage Therapeutics, Inc. annual Return On Equity for 2021 was -24.4 %, a 144% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -58 -21 -56.7% Jan 1, 2023 Dec 31, 2023
2022 -37 -12.6 -51.6% Jan 1, 2022 Dec 31, 2022
2021 -24.4 -80.6 -144% Jan 1, 2021 Dec 31, 2021
2020 56.1 +116 Jan 1, 2020 Dec 31, 2020
2019 -59.8 -22.4 -60% Jan 1, 2019 Dec 31, 2019
2018 -37.4 +48.8 +56.6% Jan 1, 2018 Dec 31, 2018
2017 -86.1 -38.2 -79.7% Jan 1, 2017 Dec 31, 2017
2016 -47.9 +6.4 +11.8% Jan 1, 2016 Dec 31, 2016
2015 -54.3 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.